Patients
Developing new cancer therapies and improving the quality of patients’ lives is at the heart of everything we do. Our mission is to target previously untreatable common cancers by exposing and impacting newly discovered drivers of metastasis, thus converting cancer to a manageable, chronic condition.
Actively Recruiting Patients
Clinical trials are an essential part of discovering new cancer therapies and making them available to those in need. We are actively seeking patient volunteers for the following clinical trials.
Ompenaclid (RGX-202)
This study is designed to evaluate ompenaclid (RGX-202) in combination with standard-of-care therapy. Patients diagnosed with advanced colorectal cancer may be able to participate in our clinical trial.
- COLORECTAL
Abequolixron (RGX-104)
This study is designed to evaluate abequolixron (RGX-104) in combination with other agents, including standard-of-care therapy. Patients diagnosed with advanced NSCLC or endometrial cancer may be able to participate in our clinical trial.
- NON-SMALL CELL LUNG CANCER
- ENDOMETRIAL CANCER